[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100633265":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":28,"centralContacts":32,"locations":42,"responsibleParty":61,"collaborators":10,"id":63,"slug":10,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":64,"sex":68,"minAge":69,"maxAge":10,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":83,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University of Alberta","OTHER",[8,13],{"label":9,"type":6,"description":10,"interventionNames":11},"Standard care alone",null,[12],"Other: Standard of Care",{"label":14,"type":15,"description":10,"interventionNames":16},"Adjunctive 0.5% β-glucan cream combined with standard care","EXPERIMENTAL",[17],"Drug: Soothing Beta Cream (Dr. Mom)",[19,24],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DRUG","Soothing Beta Cream (Dr. Mom)","Website Description: Soothe and protect sensitive skin with the by Dr Mom Beta-Glucan Cream, a physician-developed, hypoallergenic moisturizer recommended by healthcare professionals for the relief of dry, itchy, irritated skin. Powered by beta-glucan-a naturally derived fiber shown in scientific studies to improve skin hydration and support healing-this gentle cream helps calm inflammation while strengthening the skin barrier.",[14],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"Standard of Care","Current Standard of Care for IAD treatment: Standard of care for IAD management is cleansing followed by application of barrier protection. The cleanser is either with Skintegrity™ Wound Cleanser or normal saline for sensitive skin, and the barrier product is Baza® Protect II Zinc Oxide Skin Protectant Cream (a zinc oxide and dimethicone product) for mild or intact IAD or Coloplast Critic-Aid Clear (a petrolatum and dimethicone product) for moderate to severe IAD.",[9],[29],{"name":30,"affiliation":5,"role":31},"Marlene Dytoc, MD\u002FPhD","PRINCIPAL_INVESTIGATOR",[33,39],{"name":34,"role":35,"phone":36,"phoneExt":37,"email":38},"Eileen Tang, BSc","CONTACT","7802636245","1","eatang@ualberta.ca",{"name":30,"role":35,"phone":40,"phoneExt":37,"email":41},"7802319335","mdytoc@mdskinhealth.com",[43],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"University of Alberta Hospital","RECRUITING","Edmonton","Alberta","T6G2J2","Canada","CA",{"type":52,"coordinates":53},"Point",[54,55],-113.46871,53.55014,{"lat":55,"lon":54},[58],{"name":30,"role":35,"phone":59,"phoneExt":37,"email":60},"780-407-8822","supportg@ualberta.ca",{"type":62,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100633265",false,"NCT07524439","Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent","Eligible participants are adults (≥18 years) with IAD secondary to urinary and\u002For fecal incontinence and an expected hospital stay of ≥7 days. Written informed consent will be obtained directly or via substitute decision-maker. Exclusion criteria include absence of IAD or incontinence, pediatric patients, and participants with known hypersensitivities to components of cream (e.g. beta-glucan).","ALL","18 Years",{"count":71,"type":72},60,"ESTIMATED","INTERVENTIONAL",[75],"NA","The goal of this clinical trial is to determine whether adding a β-glucan moisturizing cream to routine skin care can enhance skin healing, accelerate visible recovery, reduce discomfort, and improve both patient and clinician experiences. The study will also learn about the safety and tolerability of the β-glucan cream when used along with standard skin care.\n\nThe main questions it aims to answer are:\n\nAre there visible changes in the severity of IAD when β-glucan cream is added to standard care, and if so, to what extent does it reduce severity compared with standard care alone?\n\nDoes the β-glucan cream help IAD heal faster?\n\nDoes the cream reduce symptoms such as pain, itching, tingling, or burning?\n\nWhat medical problems or side effects, if any, do participants experience while using the β-glucan cream?\n\nResearchers will compare standard care plus β-glucan cream to standard care alone to see if the β-glucan cream provides additional benefit for treating IAD.\n\nParticipants will:\n\nReceive either β-glucan cream plus standard care or standard care alone\n\nHave the study cream applied once daily for up to 2 weeks\n\nHave their skin checked weekly by the study team using a standardized assessment tool\n\nAnswer questions about symptoms such as pain, itching, tingling, and burning\n\nAllow photographs of the affected skin area to be taken for secure clinical review\n\nBe monitored for any side effects or skin reactions during the study",[78,79,80,81,82],"Fecal Incontinence","Urinary Incontinence","Diaper Rash","Irritant Contact Dermatitis Caused by Faeces","Irritant Contact Dermatitis",[84,85],"Administration, Topical","Administration, Cutaneous","2026-06-23",{"date":88,"type":89},"2026-06-26","ACTUAL",{"date":91,"type":89},"2026-05-01",{"date":93,"type":72},"2028-11-30",{"name":5,"class":6},1]